Nuvalent (NUVL) Enterprise Value Growth (1y) (2021 - 2026)
Nuvalent (NUVL) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Nuvalent |
9.70 Bn |
9.70 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-19.96% |
| Dec 31, 2025 |
-22.68% |
| Sep 30, 2025 |
19.28% |
| Jun 30, 2025 |
-52.83% |
| Mar 31, 2025 |
-55.13% |
| Dec 31, 2024 |
-55.34% |
| Sep 30, 2024 |
-182.71% |
| Jun 30, 2024 |
-52.58% |
| Mar 31, 2024 |
-53.58% |
| Dec 31, 2023 |
-52.47% |
| Sep 30, 2023 |
-72.14% |
| Jun 30, 2023 |
-67.82% |
| Mar 31, 2023 |
-65.17% |
| Dec 31, 2022 |
-63.88% |
| Sep 30, 2022 |
20.62% |
| Dec 31, 2021 |
-2,688.53% |
| Sep 30, 2021 |
-1,882.62% |
